HFZS
839725
Hangzhou SDIC Microelectronics Inc.
688130
Henan Liliang Diamond
301071
Sf Diamond Co., Ltd.
300179
Jiangsu Zhengdan Chemical Industry
300641
CN Stock MarketDetailed Quotes
603970 Sino-Agri Leading Biosciences
- 14.54
- -0.65-4.28%
Not Open Dec 23 15:00 CST
3.91BMarket Cap17.93P/E (TTM)
15.25High14.52Low30.51KlotVolume15.11Open15.19Pre Close45.08MTurnover1.14%Turnover Ratio17.39P/E (Static)268.80MShares20.7552wk High2.62P/B3.91BFloat Cap11.4952wk Low16.71Limit Up268.80MShs Float26.56Historical High13.67Limit Down4.81%Amplitude6.45Historical Low0.45Dividend TTM14.78Avg Price19.36KlotAsk3.09%Div YieldTTM100Lot Size10.67KlotBid
Sino-Agri Leading Biosciences Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | 20.72%7.35B | 14.84%4.82B | 7.19%1.82B | -23.99%8.24B | -25.72%6.09B | -19.22%4.2B | -18.81%1.7B | 25.53%10.84B | 36.35%8.2B | 25.37%5.2B |
| Refunds of taxes and levies | -36.24%73.85M | -56.96%40.39M | -68.77%23.06M | -46.72%142.05M | -41.32%115.83M | -3.39%93.84M | 54.16%73.84M | 88.57%266.59M | 91.01%197.38M | 53.27%97.12M |
| Cash received relating to other operating activities | 98.88%425.45M | 8.21%335.72M | -1.94%230.8M | 490.86%378.58M | 348.66%213.92M | 521.53%310.24M | 616.77%235.37M | -72.97%64.07M | -36.34%47.68M | 19.13%49.92M |
| Cash inflows from operating activities | 22.29%7.85B | 12.93%5.2B | 3.33%2.08B | -21.58%8.76B | -23.97%6.42B | -13.88%4.6B | -7.61%2.01B | 23.92%11.18B | 36.38%8.44B | 25.72%5.34B |
| Goods services cash paid | 13.24%7.78B | 11.58%5.48B | 2.50%2.64B | -5.28%8.49B | -5.58%6.87B | -3.08%4.91B | 7.61%2.58B | 8.25%8.96B | 6.81%7.27B | 16.40%5.07B |
| Staff behalf paid | 2.06%155.82M | -0.38%116.21M | -1.84%65.09M | 15.37%190.32M | 13.00%152.67M | 14.70%116.66M | 11.96%66.31M | 12.29%164.97M | 14.84%135.11M | 19.90%101.71M |
| All taxes paid | -14.56%88.96M | -15.65%62.15M | -37.33%16.66M | 60.06%123.81M | 75.73%104.11M | 116.36%73.68M | 241.02%26.58M | 6.15%77.36M | 1.35%59.25M | -15.18%34.05M |
| Cash paid relating to other operating activities | -70.42%223M | -63.96%157.78M | -53.84%50.37M | 107.96%904.97M | 76.54%753.89M | 90.78%437.79M | 37.32%109.13M | 125.23%435.17M | 121.86%427.03M | -5.20%229.47M |
| Cash outflows from operating activities | 4.65%8.24B | 4.99%5.81B | -0.20%2.78B | 0.71%9.71B | -0.21%7.88B | 1.97%5.54B | 9.35%2.78B | 10.90%9.64B | 9.98%7.89B | 15.09%5.43B |
| Net cash flows from operating activities | 73.02%-393.63M | 34.06%-617.1M | 9.39%-699M | -161.49%-944.21M | -366.01%-1.46B | -971.51%-935.9M | -109.61%-771.44M | 371.89%1.54B | 155.53%548.38M | 81.36%-87.34M |
| Investing cash flow | ||||||||||
| Cash received from disposal of investments | 2.34%2.93B | 0.09%2.13B | 236.57%1.01B | 4.43%3.59B | -2.42%2.86B | 0.14%2.12B | -63.28%300M | 31.52%3.43B | 57.83%2.93B | 64.42%2.12B |
| Cash received from returns on investments | -65.82%6.54M | -74.61%3.93M | -15.19%3.29M | 166.94%24.35M | 239.13%19.12M | 493.39%15.49M | 179.89%3.88M | -72.04%9.12M | -82.36%5.64M | -90.03%2.61M |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | 49.99%92.76K | 8,695.00%79.16K | 3,950.56%36.46K | 5,117.11%20.07M | -83.87%61.84K | -98.76%900 | -96.26%900 | -66.60%384.61K | -58.15%383.41K | -84.62%72.73K |
| Cash inflows from investing activities | 1.89%2.94B | -0.44%2.13B | 233.37%1.01B | 5.43%3.63B | -1.97%2.88B | 0.74%2.14B | -62.87%303.88M | 26.09%3.44B | 53.20%2.94B | 58.03%2.12B |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | -3.76%2.05M | -5.88%1.74M | 738.74%817.3K | 26.92%4.37M | -13.65%2.12M | 653.90%1.84M | 41.95%97.44K | -13.75%3.44M | 20.95%2.46M | -95.81%244.69K |
| Cash paid to acquire investments | 0.16%2.58B | -5.34%1.74B | 314.62%812.66M | -15.74%3.38B | -12.22%2.58B | -13.69%1.83B | -75.44%196M | 51.26%4.01B | 99.05%2.94B | 73.33%2.13B |
| Cash outflows from investing activities | 0.15%2.59B | -5.34%1.74B | 314.83%813.48M | -15.70%3.38B | -12.22%2.58B | -13.62%1.84B | -75.43%196.1M | 51.17%4.01B | 98.94%2.94B | 72.52%2.13B |
| Net cash flows from investing activities | 16.78%351.58M | 29.19%392.27M | 85.17%199.57M | 144.08%249.91M | 68,518.65%301.06M | 19,539.70%303.64M | 429.88%107.78M | -826.69%-566.93M | -100.10%-440.02K | -101.39%-1.56M |
| Financing cash flow | ||||||||||
| Cash received from capital contributions | --7.97M | --7.5M | ---- | ---- | ---- | ---- | ---- | --28.93M | --19.29M | --19.29M |
| -Including: Cash received from capital contributions by minority shareholders of subsidiaries | --7.97M | --7.5M | ---- | ---- | ---- | ---- | ---- | --28.93M | --19.29M | --19.29M |
| Cash from borrowing | -16.88%1.08B | 149.79%1.05B | --602M | 18.87%1.43B | 8.17%1.3B | -61.64%422M | ---- | -23.81%1.2B | -5.89%1.2B | 15.17%1.1B |
| Cash received relating to other financing activities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --420K | ---- | ---- |
| Cash inflows from financing activities | -16.26%1.09B | 151.57%1.06B | --602M | 16.03%1.43B | 6.46%1.3B | -62.30%422M | ---- | -21.95%1.23B | -4.38%1.22B | 17.19%1.12B |
| Borrowing repayment | 1.71%1.12B | -21.29%629.66M | -40.00%300M | 28.77%1.6B | -11.36%1.1B | -10.21%800M | -37.50%500M | -29.39%1.24B | 10.70%1.24B | -19.07%891M |
| Dividend interest payment | 13.66%157.1M | 16.01%151.21M | 56.81%7.65M | 47.55%144.92M | 51.27%138.22M | 54.45%130.34M | -21.40%4.88M | -17.08%98.22M | -9.98%91.37M | 13.14%84.39M |
| -Including:Cash payments for dividends or profit to minority shareholders | -23.16%16.5M | -14.59%16.5M | ---- | 447.87%21.48M | 447.87%21.48M | 392.86%19.32M | ---- | -83.49%3.92M | -80.14%3.92M | 33.33%3.92M |
| Cash payments relating to other financing activities | -7.04%10.69M | -22.80%4.95M | -26.34%3.86M | -12.54%11.72M | 9.24%11.5M | 21.60%6.41M | --5.24M | 9.64%13.4M | 33.76%10.53M | 899.43%5.27M |
| Cash outflows from financing activities | 2.95%1.29B | -16.11%785.82M | -38.93%311.51M | 29.72%1.75B | -6.94%1.25B | -4.48%936.75M | -36.73%510.12M | -28.37%1.35B | 9.14%1.34B | -16.62%980.67M |
| Net cash flows from financing activities | -513.58%-199.67M | 153.58%275.81M | 156.95%290.49M | -166.29%-328.26M | 139.06%48.28M | -471.34%-514.75M | -211.74%-510.12M | 60.64%-123.27M | -377.00%-123.62M | 162.71%138.62M |
| Net cash flow | ||||||||||
| Exchange rate change effecting cash and cash equivalents | 164.30%10.94M | 198.64%13.06M | 80.47%-2.23M | 82.95%-15.31M | 35.87%-17.02M | -362.67%-13.24M | -208.58%-11.41M | -1,180.48%-89.78M | -2,683.17%-26.53M | -140.87%-2.86M |
| Net increase in cash and cash equivalents | 79.51%-230.77M | 105.52%64.04M | 82.18%-211.17M | -237.35%-1.04B | -383.17%-1.13B | -2,576.38%-1.16B | -136.64%-1.19B | 666.80%755.62M | 179.43%397.8M | 108.10%46.85M |
| Add:Begin period cash and cash equivalents | -65.36%550.16M | -65.36%550.16M | -65.36%550.16M | 90.78%1.59B | 90.78%1.59B | 90.78%1.59B | 90.78%1.59B | 13.43%832.4M | 13.43%832.4M | 13.43%832.4M |
| End period cash equivalent | -30.81%319.39M | 43.58%614.2M | -15.85%338.99M | -65.36%550.16M | -62.48%461.58M | -51.35%427.77M | 21.49%402.83M | 90.78%1.59B | 427.87%1.23B | 466.77%879.25M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Tianji International Accounting Firm (Special General Partnership) | -- | -- | -- | Tianji International Accounting Firm (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
